Patent ID: 7342013

Claim:
A compound of the formula: wherein: A-Q is selected from the group consisting of: R 1a is hydrogen or fluoro, R 1d1 is selected from the group consisting of H, -Me, —F, —Cl, —Br, aryl, heteroaryl, —NH 2 , —NMe 2 , —NHMe, —NHSO 2 Me, —NHCOMe, —CH 3 , —CF 3 , —OH, —OCH 3 , —SCH 3 , —OCF 3 , —OCH 2 F, —OCHF 2 , —OCH 2 CF 3 , —OCF 2 CF 3 , —NO 2 , —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CONHMe, —CONMe 2 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , —CH 2 OH, —CH 2 NH 2 , —CH 2 NHMe, —CH 2 NMe 2 , —OCH 2 CO 2 H, —OCH 2 CO 2 Me, —OCH 2 CO 2 Et, —OCH 2 CONH 2 , —OCH 2 CONMe 2 , —OCH 2 CONHMe, —OCH 2 CH 2 OMe, —OCH 2 CH 2 OEt, —OCH 2 CH 2 NH 2 , —OCH 2 CH 2 NHMe, —OCH 2 CH 2 NMe 2 , —NHCH 2 CH 2 OMe, —SCH 2 CH 2 OMe, —SO 2 CH 2 CH 2 OMe, —OCH 2 CH 2 SO 2 Me, —NHCH 2 CH 2 NMe 2 , —NHCH 2 CH 2 NMe 2 , —N(CH 2 CH 2 OH) 2 ; —N(CH 2 CH 2 OMe) 2 , —NHCH 2 CO 2 H, —NHCH 2 CO 2 ,Et, —NHCH 2 CO 2 Et, —NHCH 2 CONH 2 , —NHCH 2 CONMe 2 , —NHCH 2 CONHMe, —N(CH 3 )CH 2 CO 2 H, —N(CH 3 )CH 2 CO 2 Et, —(NMe)CH 2 COOH, —N(Me)CH 2 CONH 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe, —NHCH 2 CH 2 OMe, or a pharmaceutically acceptable isomer, salt, hydrate, solvate or prodrug thereof.